Cargando…
Navigating the treatment landscape in multiple myeloma: which combinations to use and when?
Multiple myeloma is one of the most common hematological malignancies, affecting mainly elderly patients. The treatment landscape for the management of this disease has evolved significantly over the past 15 years, and a vast array of therapeutics is now available, including immunomodulatory drugs,...
Autores principales: | Goldschmidt, Hartmut, Ashcroft, John, Szabo, Zsolt, Garderet, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334731/ https://www.ncbi.nlm.nih.gov/pubmed/30470875 http://dx.doi.org/10.1007/s00277-018-3546-8 |
Ejemplares similares
-
Posttransplant maintenance therapy in multiple myeloma: the changing landscape
por: Sengsayadeth, S, et al.
Publicado: (2017) -
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
por: Caers, Jo, et al.
Publicado: (2018) -
Roadmap for new practitioners to navigate the multiple myeloma landscape
por: Tam, Tiffany, et al.
Publicado: (2022) -
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment
por: Morè, Sonia, et al.
Publicado: (2023) -
Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?
por: Gahrton, Gösta, et al.
Publicado: (2020)